Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
To examine the safety and efficacy of long term administration of aripiprazole as an
adjunctive therapy, co-administered with either a selective serotonin reuptake inhibitor
(SSRI) or a selective-norepinephrine reuptake inhibitor (SNRI), in subjects with major
depressive disorder.